Healthcare provider profile · identity verified

Kendall Erdahl, MD

Family Practice · TROY, OH · NPI 1427263292

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	368	114
Omeprazole	Omeprazole	263	100
Atorvastatin Calcium	Atorvastatin Calcium	252	98
Amlodipine Besylate	Amlodipine Besylate	210	76
Lisinopril	Lisinopril	191	69
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	178	34
Tizanidine Hcl	Tizanidine Hcl	171	65
Gabapentin	Gabapentin	155	49
Pantoprazole Sodium	Pantoprazole Sodium	150	42
Rosuvastatin Calcium	Rosuvastatin Calcium	127	48
Lorazepam	Lorazepam	124	26
Furosemide	Furosemide	118	39
Alprazolam	Alprazolam	113	27
Albuterol Sulfate Hfa	Albuterol Sulfate	106	39
Sertraline Hcl	Sertraline Hcl	105	33
Prednisone	Prednisone	104	56
Trazodone Hcl	Trazodone Hcl	103	42
Losartan Potassium	Losartan Potassium	99	41
Tramadol Hcl	Tramadol Hcl	92	31
Montelukast Sodium	Montelukast Sodium	87	26
Metformin Hcl	Metformin Hcl	86	36
Diclofenac Sodium	Diclofenac Sodium	85	34
Eliquis	Apixaban	84	18
Tamsulosin Hcl	Tamsulosin Hcl	83	31
Metoprolol Succinate	Metoprolol Succinate	81	25
Pioglitazone Hcl	Pioglitazone Hcl	74	18
Fluoxetine Hcl	Fluoxetine Hcl	70	18
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	67	15
Meloxicam	Meloxicam	66	31
Pravastatin Sodium	Pravastatin Sodium	65	30
Simvastatin	Simvastatin	63	28
Celecoxib	Celecoxib	62	15
Hydrochlorothiazide	Hydrochlorothiazide	62	20
Januvia	Sitagliptin Phosphate	60	11
Fluticasone Propionate	Fluticasone Propionate	57	25
Jardiance	Empagliflozin	55	19
Venlafaxine Hcl Er	Venlafaxine Hcl	55	16
Zolpidem Tartrate	Zolpidem Tartrate	55	18
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	54	13
Duloxetine Hcl	Duloxetine Hcl	54	18
Donepezil Hcl	Donepezil Hcl	53	suppressed
Famotidine	Famotidine	53	14
Metoprolol Tartrate	Metoprolol Tartrate	53	19
Glipizide Er	Glipizide	51	17
Hydroxyzine Hcl	Hydroxyzine Hcl	49	19
Escitalopram Oxalate	Escitalopram Oxalate	48	18
Ibuprofen	Ibuprofen	48	16
Buspirone Hcl	Buspirone Hcl	47	12
Diazepam	Diazepam	47	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	46	19
Clopidogrel	Clopidogrel Bisulfate	43	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	43	17
Pregabalin	Pregabalin	42	12
Naproxen	Naproxen	41	15
Topiramate	Topiramate	41	11
Clonazepam	Clonazepam	40	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	40	33
Carvedilol	Carvedilol	39	14
Sumatriptan Succinate	Sumatriptan Succinate	38	suppressed
Trulicity	Dulaglutide	38	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	37	33
Methocarbamol	Methocarbamol	36	14
Risperidone	Risperidone	36	suppressed
Fluconazole	Fluconazole	34	17
Hydralazine Hcl	Hydralazine Hcl	33	suppressed
Metformin Hcl Er	Metformin Hcl	33	18
Bupropion Xl	Bupropion Hcl	32	13
Methylprednisolone	Methylprednisolone	32	27
Amitriptyline Hcl	Amitriptyline Hcl	31	suppressed
Baclofen	Baclofen	31	11
Mirtazapine	Mirtazapine	31	suppressed
Glimepiride	Glimepiride	30	suppressed
Atenolol	Atenolol	29	12
Synthroid	Levothyroxine Sodium	29	14
Ondansetron Hcl	Ondansetron Hcl	27	11
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	27	12
Triamcinolone Acetonide	Triamcinolone Acetonide	27	14
Allopurinol	Allopurinol	26	suppressed
Estradiol	Estradiol	26	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	26	suppressed
Spironolactone	Spironolactone	26	suppressed
Testosterone Cypionate	Testosterone Cypionate	26	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	26	11
Warfarin Sodium	Warfarin Sodium	26	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	25	suppressed
Ipratropium Bromide	Ipratropium Bromide	24	suppressed
Nystatin	Nystatin	23	15
Citalopram Hbr	Citalopram Hydrobromide	22	suppressed
Eszopiclone	Eszopiclone	22	suppressed
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Promethazine Hcl	Promethazine Hcl	22	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	21	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	21	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	20	suppressed
Potassium Chloride	Potassium Chloride	20	suppressed
Ezetimibe	Ezetimibe	19	suppressed
Fenofibrate	Fenofibrate	19	suppressed
Glipizide	Glipizide	19	suppressed
Synjardy Xr	Empagliflozin/Metformin Hcl	19	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	19	suppressed
Bupropion Hcl	Bupropion Hcl	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Hydrocortisone	Hydrocortisone	18	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Np Thyroid	Thyroid,pork	18	suppressed
Valsartan	Valsartan	18	suppressed
Aripiprazole	Aripiprazole	17	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	17	11
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	17	suppressed
Mounjaro	Tirzepatide	17	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	17	suppressed
Ozempic	Semaglutide	17	suppressed
Sucralfate	Sucralfate	17	suppressed
Verapamil Er	Verapamil Hcl	17	suppressed
Klor-Con M20	Potassium Chloride	16	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	12
Xarelto	Rivaroxaban	16	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Fenofibrate	Fenofibrate,micronized	15	suppressed
Olanzapine	Olanzapine	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Cilostazol	Cilostazol	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Azithromycin	Azithromycin	13	12
Cephalexin	Cephalexin	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Levofloxacin	Levofloxacin	13	12
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	11
Alendronate Sodium	Alendronate Sodium	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	suppressed
Benztropine Mesylate	Benztropine Mesylate	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Carbamazepine Er	Carbamazepine	12	suppressed
Cefdinir	Cefdinir	12	11
Clonidine Hcl	Clonidine Hcl	12	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Felodipine Er	Felodipine	12	suppressed
Liothyronine Sodium	Liothyronine Sodium	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Terbinafine Hcl	Terbinafine Hcl	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Armour Thyroid	Thyroid,pork	11	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Sodium Chloride	0.9 % Sodium Chloride	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error